Ranibizumab 0.3 mg
Sponsors
Novartis, Arshad Khanani
Conditions
Diabetic Macular Edema
Phase 2
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement
CompletedNCT00284050
Start: 2005-10-31End: 2008-06-30Updated: 2011-02-24
Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME
CompletedNCT02363621
Start: 2015-01-31End: 2017-10-31Updated: 2019-04-26